Biotech · Private company
VM Oncology, LLC
Track this companyFree. Adds VM Oncology, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VMD-928 100 mg TabletPhase 2 · Head and Neck CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VMD-928 Tablet and Pembrolizumab (200 mg)Phase 2 · Head and Neck CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1_PHASE2 · RECRUITING · started Jun 8, 2018ClinicalTrials.gov NCT03556228 · fetched Nov 12, 2026